Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents

NCT01535183 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumor

Interventions

DRUG: Irinotecan combination chemotherapy

Sponsor

Seoul National University Hospital